Premium
Effects of intravesical instillation of cyclooxygenase‐2 inhibitor on the expression of inducible nitric oxide synthase and nerve growth factor in cyclophosphamide‐induced overactive bladder
Author(s) -
JANG JOON,
PARK EUN YOUNG,
SEO SEONG IL,
HWANG TAEKON,
KIM JOON CHUL
Publication year - 2006
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/j.1464-410x.2006.06207.x
Subject(s) - nitric oxide synthase , cystometry , nerve growth factor , cyclooxygenase , medicine , overactive bladder , nitric oxide , contraction (grammar) , urothelium , endocrinology , immunohistochemistry , pharmacology , urinary bladder , chemistry , pathology , receptor , enzyme , biochemistry , alternative medicine
OBJECTIVE To examine the effects of intravesical cyclooxygenase‐2 (COX‐2) inhibitors on the expression of inducible nitric oxide synthase (iNOS) and nerve growth factor (NGF) in cyclophosphamide (CYP)‐induced overactive bladder (OAB). MATERIALS AND METHODS In all, 40 Sprague–Dawley rats were divided into control, OAB, and COX‐2 inhibitor‐treated groups. OAB was induced by an intraperitoneal injection with CYP. Cystometry was performed in all rats and, in half of the OAB rats, a COX‐2 inhibitor was administered intravesically. The bladders of all rats were stained immunohistochemically for iNOS and NGF. RESULTS In the OAB rats, the contraction interval and intercontraction interval were significantly shorter than in control rats, and the contraction time and pressure were significantly greater. In the COX‐2 inhibitor‐treated rats, the contraction interval and intercontraction interval were significantly longer than in the OAB rats, and the contraction time was significantly shorter. On immunohistochemical staining, there was no iNOS activity and NGF activity was minimally localized in the mucosa and submucosa in the control group. In the OAB rats, NGF activity in the mucosa and submucosa were increased, and there was greater expression of iNOS in all layers and of NGF in detrusor; in the COX‐2 inhibitor‐treated rats, their expression was less in all layers. CONCLUSIONS Intravesical instillation with COX‐2 inhibitors can reduce CYP‐induced bladder hyperactivity and expression of iNOS and NGF. Intravesical instillation with COX‐2 inhibitors can be considered as a possible treatment for OAB.